Class II Recall: Preferred Pharmaceuticals Artificial Tears Eye Drops
Summary
FDA classified a Class II recall initiated by Preferred Pharmaceuticals for Artificial Tears Lubricant Eye Drops (NDC 68788-7266) due to lack of assurance of sterility. The recall covers 720 bottles across six lot numbers (F1924R, F2024G, F2424E, G2424M, G2624P, J2424M) distributed nationwide. The firm initiated the recall on March 25, 2026; FDA classification occurred on April 7, 2026.
“Lack of Assurance of Sterility”
What changed
Preferred Pharmaceuticals voluntarily initiated a recall of 720 bottles of Artificial Tears Lubricant Eye Drops manufactured by Geri-Care (Brooklyn, NY) after concerns arose regarding sterility assurance. FDA classified the recall as Class II, indicating temporary or reversible health consequences where use of the product may cause adverse health consequences or a remote possibility of serious health consequences.
Healthcare providers, pharmacies, and distributors that received this product should verify their inventory against the six affected lot numbers (F1924R, F2024G, F2424E, G2424M, G2624P, J2424M) and should not dispense bottles from these lots. Patients experiencing any adverse events associated with use of this product should consult their healthcare provider.
Archived snapshot
Apr 20, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Preferred Pharmaceuticals, Inc.
Drug Recalls (Class II)
← All Drug Recalls (Class II) Class II D-0443-2026 · 20260415 · Ongoing · Voluntary: Firm initiated
Product
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0
Reason for Recall
Lack of Assurance of Sterility
Affected Lot Numbers / Codes
Lot #: F1924R, F2024G, F2424E, G2424M, G2624P, J2424M
Quantity
720 bottles
Distribution
Nationwide within the United States
Initiated
20260325
FDA Classified
20260407
Product Registration
Brand: ARTIFICIAL TEARS
Generic: GLYCERIN
Manufacturer: Preferred Pharmaceuticals Inc.
Application: MO18
NDC: 68788-7266
Drug Label Context (from openFDA)
The following is from the manufacturer's FDA-approved drug label, not recall-specific. Provided for context.
Indications & Usage
Uses • for protection against further irritation • for temporary relief of burning and irritation due to dryness of the eye
Dosage & Administration
Directions • instill 1 or 2 drops in the affected eye(s) as needed • children under 6 years of age: ask a doctor
Warnings
Warnings For external use only Do not use this product if solution changes color or becomes cloudy
Storage & Handling
Other information • store at 15°-30°C (59°-86°F)
Related changes
Get daily alerts for FDA Drug Recalls (Class II)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Drug Recalls (Class II) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.